Premenstrual syndrome

EMS Kegel Trainer BODYDOCTOR Opens New Era of Health Care Solutions in Global Femcare Market

Retrieved on: 
Friday, March 29, 2024

This innovative solution enables people to do Kegel exercises easily by sitting on it, heralding a new era of K-HEALTH CARE.

Key Points: 
  • This innovative solution enables people to do Kegel exercises easily by sitting on it, heralding a new era of K-HEALTH CARE.
  • View the full release here: https://www.businesswire.com/news/home/20240327264174/en/
    The EMS Kegel Trainer BODYDOCTOR FEMFIT has been launched in Japan.
  • (Photo: GENERALNET CORP)
    Derived from combining 'Feminine' and 'Care', the term 'Femcare' encompasses products and services designed to care for women’s bodies and health.
  • Understanding how important it is to strengthen pelvic floor muscles to address these health issues, GENERALNET CORP, a company dedicated to women's health and beauty, launched the EMS Kegel exerciser BODYDOCTOR in January 2019.

Perinatal depression linked with premenstrual mood disorders – new research

Retrieved on: 
Friday, April 5, 2024

But for the millions of women who have a premenstrual disorder, such as severe premenstrual syndrome (PMS) or premenstrual dysphoric disorder (PMDD), these mood changes can be far more severe than normal.

Key Points: 
  • But for the millions of women who have a premenstrual disorder, such as severe premenstrual syndrome (PMS) or premenstrual dysphoric disorder (PMDD), these mood changes can be far more severe than normal.
  • Premenstrual disorders manifest through a range of symptoms – including mood swings, irritability and fatigue.
  • Our study found that women who have a premenstrual disorder may also be at greater risk of depression during or after pregnancy.
  • Having a premenstrual disorder may also partly explain why mental health problems may be more common in young women.

Perinatal depression

  • The hormonal fluctuations that happen during and after pregnancy can also precipitate a unique form of turmoil: perinatal depression.
  • Historically, the threads connecting premenstrual disorders and perinatal depression have been recognised anecdotally.
  • We revealed that women with a history of premenstrual disorders are five times more susceptible to developing perinatal depression if they become pregnant.
  • Read more:
    Maternal mental health problems – the impact in numbers

    Moreover, our study is the first to draw connections not just to postnatal depression (depression after childbirth) but also antenatal depression (depression during pregnancy).

  • We also showed that women who experience perinatal depression are at a higher risk of encountering premenstrual disorders later on.

Advocate for mental health

  • It also suggests that women with a history of premenstrual disorders should be closely screened for perinatal depression, and provided with the help and resources they may need for their mental health before and during pregnancy, and just after giving birth.
  • Moreover, it encourages women themselves to advocate for their mental health, armed with the understanding that their experiences before and during pregnancy are not isolated – but part of a broader hormonal narrative that needs addressing.


Donghao Lu receives funding from the Swedish Research Council, Swedish Research Council for Health, Working Life and Welfare, and Karolinska Institutet.

Menstrual health literacy is alarmingly low – what you don’t know can harm you

Retrieved on: 
Wednesday, March 13, 2024

When I ask my menstrual health workshop participants – including clinicians – there’s usually a lot of shrugging and shaking of heads.

Key Points: 
  • When I ask my menstrual health workshop participants – including clinicians – there’s usually a lot of shrugging and shaking of heads.
  • If given multiple choice options, most think that periods either “clean the womb” or somehow “help prepare for pregnancy”.
  • Yes, the blood part can stain clothing, but there is nothing pathological, contaminating, or dangerous about periods.

So, why do we have periods?

  • Periods likely evolved as a kind of preemptive abortion, to protect women from unviable or dangerous pregnancies.
  • As a result, we have low rates of conception, high rates of miscarriage, and extremely high rates of maternal mortality in comparison to other mammals.
  • The menstrual cycle is critical for facilitation of the initial steps of this raison d’être of the female reproductive system.
  • The menstrual cycle is critical for facilitation of the initial steps of this raison d’être of the female reproductive system.

What else don’t we know?

  • Perhaps with the fact that the second phase of the cycle from ovulation to menstruation is a series of highly inflammatory processes.
  • This was only very briefly mentioned in three out of 16 textbooks.
  • We really ought to be taught from puberty how to reduce period pain and blood loss – this is not difficult science.

Why aren’t we taught this stuff?

  • My research shows that the exclusive focus on the female sex hormones in menstrual education is informed by societal influences, such as the myth of the hysterical or hormonal female.
  • This gender myth is still alive and well, although now we tend to blame the (female sex) hormones.
  • Again, there was no scientific reason for this change in focus, although it reflected existing societal beliefs about the inherently irrational behaviour of women.
  • Unfortunately, menstrual health literacy has not yet recovered from this shift in physiological models.

So what?

  • It also becomes much easier to differentiate premenstrual changes from underlying health conditions, since the latter will not be substantially alleviated by anti-inflammatory interventions alone.
  • Teaching the reductive hormonal model of the menstrual cycle unintentionally provides pseudo-scientific evidence for the damaging hormonal or hysterical female gender myth.


Sally King is the founder of Menstrual Matters- the world's first evidence-based info hub on menstrual health and rights www.menstrual-matters.com. Her doctoral research and current research fellowship were funded by the ESRC (Economic and Social Research Council).

Herbal medicinal product: Agni casti fructusArray, C: ongoing call for scientific data

Retrieved on: 
Friday, February 16, 2024

Herbal medicinal product: Agni casti fructusArray, C: ongoing call for scientific data

Key Points: 


Herbal medicinal product: Agni casti fructusArray, C: ongoing call for scientific data

Flo for Partners Now Available: Unlocking Better Sex, Conception and Communication among Couples

Retrieved on: 
Thursday, October 19, 2023

Flo for Partners emerged as the #1 most requested feature in 2022, reflecting a growing demand for better education and understanding surrounding women's health.

Key Points: 
  • Flo for Partners emerged as the #1 most requested feature in 2022, reflecting a growing demand for better education and understanding surrounding women's health.
  • The lack of knowledge, misinformation and poor communication can also lead to a sexual disconnect between the partners.
  • "Flo for Partners is Flo's most requested feature – and for good reason," said Cath Everett, VP of Product and Content at Flo.
  • Flo remains committed to its mission of creating a better future for female health, and the protection of sensitive health information remains a top priority for Flo.

IGC Pharma Reports First Quarter Results; Company Continues to Make Significant Progress Advancing Its Lead Alzheimer’s Candidate Through Phase 2 Clinical Trials

Retrieved on: 
Monday, August 14, 2023

IGC Pharma, Inc. (“IGC” or the “Company”) (NYSE American: IGC) today announced its financial results for the quarter ended June 30, 2023, which is the first quarter of the Company’s 2024 fiscal year.

Key Points: 
  • IGC Pharma, Inc. (“IGC” or the “Company”) (NYSE American: IGC) today announced its financial results for the quarter ended June 30, 2023, which is the first quarter of the Company’s 2024 fiscal year.
  • Throughout the quarter, IGC Pharma maintained substantial momentum in the development of a Phase 3 manufacturing facility located on the West Coast, including augmentation of distillation capacity.
  • Ram Mukunda, Chief Executive Officer of IGC Pharma, commented, “Our first fiscal quarter of 2024 was highlighted by substantial progress in our efforts to advance our lead drug asset, IGC-AD1, through Phase 2 clinical trials on Alzheimer’s.
  • However, the Company expects R&D expenses to increase from the current levels as enrollment in the Phase 2 trial expands.

Your Super’s Moon Balance Superfood Blend Reduced Period Symptoms in 86% of Clinical Trial Participants

Retrieved on: 
Thursday, July 27, 2023

Eighty-six percent of clinical trial participants experienced less painful periods after two months of consistent use, while 80% said their premenstrual syndrome (PMS) and menstrual symptoms had improved.

Key Points: 
  • Eighty-six percent of clinical trial participants experienced less painful periods after two months of consistent use, while 80% said their premenstrual syndrome (PMS) and menstrual symptoms had improved.
  • Topline results from the clinical trial include:
    Reduced Pain & Discomfort: Participants reported their menstrual cramps were less severe (by 33%), bloating symptoms improved (by 30%) and they ultimately experienced fewer days of PMS symptoms overall.
  • “When Your Super launched Moon Balance three years ago, it was purposefully formulated to improve female health,” said Anabel Oelmann, Co-Founder of The Healing Company.
  • With more than three thousand five-star customer reviews, Moon Balance is consistently one of Your Super’s top rated and highest selling products.

American women need improved access to medically credible information as Flo Health's nationwide survey identifies devastating knowledge gaps

Retrieved on: 
Thursday, May 11, 2023

LONDON, May 11, 2023 /PRNewswire/ -- Flo Health, the most popular women's health app globally with 50 million monthly active users, is today releasing its inaugural report titled "Failed foundations: The women's health crisis in post-Roe America." In the aftermath of the historic overturn of Roe v. Wade, American women face endless challenges: Health clinics are closing,1,2 doctors and women fear prosecution for providing or accessing care,3 the education system is limiting health education curriculum,4 and misinformation about women's health topics runs rampant on social media.5

Key Points: 
  • How can Flo better help women source and identify credible information?
  • Flo Health sought to find the answers, share medically credible information, and provide key predictions on what may influence American women in the future.
  • Flo Health wants to empower women to better understand their bodies so they can make the most informed decisions for their health."
  • Flo Health's 2023 Reproductive Health Survey was conducted in January 2023 among 2,010 online adult women ages 18 to 55 via Cint.

Flo's reproductive health survey reveals stark knowledge gaps amongst UK women

Retrieved on: 
Thursday, May 11, 2023

LONDON, May 11, 2023 /PRNewswire/ -- Flo Health, the most popular women's health app globally with 50 million monthly active users, has released the findings of a nationwide survey of women aged 18–55, highlighting a staggering degree of misinformation and prominent gaps in the knowledge women have about their own bodies.

Key Points: 
  • Flo's nationwide survey on the state of health literacy shows that 56% of UK women rely on generic advice from search engines for menstrual health information.
  • 72% of women never double-check the health information they get on social media, while nearly one in five (18%) women aged 18–24 go to social media for information around menstrual health.
  • Flo Health's 2023 UK Reproductive Health survey of 2,000 UK women aged 18–66 was commissioned by Flo Health and conducted by market research company OnePoll, in accordance with the Market Research Society's code of conduct.
  • Flo Health's 2023 US Reproductive Health survey was conducted in January 2023 among 2,010 online adult women ages 18–55 via Cint.

IGC Announces Rebranding, Changes Name to IGC Pharma, Inc.

Retrieved on: 
Monday, March 20, 2023

POTOMAC, Md., March 20, 2023 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American: IGC) (“IGC” or the “Company”) today announces it will begin operating under the new name IGC Pharma, Inc., (dba IGC) effective March 30, 2023, as part of a rebranding strategy that better reflects IGC Pharma’s strategic focus and vision for the future.

Key Points: 
  • POTOMAC, Md., March 20, 2023 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American: IGC) (“IGC” or the “Company”) today announces it will begin operating under the new name IGC Pharma, Inc., (dba IGC) effective March 30, 2023, as part of a rebranding strategy that better reflects IGC Pharma’s strategic focus and vision for the future.
  • Our common stock will continue to be quoted on the NYSE American under the same symbol IGC.
  • IGC is currently in a Phase 2 trial with its THC-based investigational medication, IGC-AD1, for the treatment of agitation in Alzheimer’s.
  • IGC also markets a wellness brand, Holief™, that targets women experiencing premenstrual syndrome, menstrual cramps and sleep disorders.